Gout Therapeutics Market Size to hit US$ 9,815.6 million by 2026, with 15.2% CAGR from 2019 to 2026 | Market Study Report
Aug 8, 2019
Market Study Report LLC has a newly added "Global Gout Therapeutics Market Report" that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, and forecast in the coming years.
Delaware, Selbyville - August 8, 2019 /MarketersMedia/ —
The incidence of gout has witnessed continual growth over the past years. It is majorly caused by uncontrolled metabolic disorder and high level of uric acid in the body. U.S. region is observed to have a high prevalence of gout owing to lifestyle issues such as high alcohol intake, obesity, and smoking resulting in the inflammatory disorder.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1868592/?utm_source=marketersmedia-SP
The global gout therapeutics market is predicted to grow at a CAGR of 15.2% from 2019 to 2026 to reach USD 9,815.6 million by 2026, according to a new market report. Attributed to these factors along with the adoption of innovative treatments and increased understanding about arthritic conditions, the market in North America region is observed to be the dominant market across all regions during 2018. While, the Asia Pacific regional market is expected to witness highest growth rate owing to rising healthcare expenditure among the developing economies and significant investments by key players in this region.
As per the severity of gout condition recommendations of medications and therapies are made to the respective patients. Multiple pharmaceutical companies have consistently increased the R&D investments to come up with further effective medications. The market for therapeutics of acute and chronic gout has witnessed significant growth over the past years and is expected to continue its growth trend. Although both segments are anticipated to grow, chronic gout segment presently holds major market share.
NSAIDs, corticosteroids are among the approved drugs for treating gout condition and are available for purchase over the counter. These drugs are observed to be greatly effective in treating mild gout conditions and are expected to have significant impact on driving the growth in global gout therapeutics market. Moreover, rising preference for combination therapies due to benefits such as speeding up the treatment process, reduction in side effects is also another factor enhancing the market growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1868592/?utm_source=marketersmedia-SP
Some of the key players in this market are AstraZeneca, Horizon Pharma plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin Pharma Limited, Regeneron Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group. Companies are also increasingly having their focus on regenerative medicines which is further expected to contribute in the growth of gout therapeutics market.
The Report has segmented the global Gout Therapeutics Market on the basis of Drug Class, Disease Condition and region:
Gout Therapeutics by Drug Class Outlook (Revenue, USD Million, 2015 - 2026)
• Topical Hemostats
• Corticosteroids
• Nonsteroidal Anti-inflammatory Drugs [NSAIDs]
• Colchicine
•
Gout Therapeutics by Disease Condition Outlook (Revenue, USD Million, 2015 - 2026)
• Chronic Gout
• Acute Gout
Table of Content:
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Global Gout Therapeutics Testing Market Insights
3.1. Gout Therapeutics Market Industry snapshot
3.2. Gout Therapeutics Market Ecosystem analysis
3.3. Gout Therapeutics Market dynamics
3.3.1. Gout Therapeutics Market Forces
3.3.1.1. Gout Therapeutics Market - Market driver analysis
3.3.1.2. Gout Therapeutics Market - Market restraint/challenges analysis
3.3.1.3. Gout Therapeutics Market - Market opportunity analysis
3.4. Industry analysis - Porter's five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Gout Therapeutics Market PEST analysis, 2017
3.6. Value Chain Analysis
3.7. Gout Therapeutics Market Industry trends
4. Gout Therapeutics Market Size and Forecast by Drug Class
5. Gout Therapeutics Market Size and Forecast by Disease Condition
6. Gout Therapeutics Market Size and Forecast by Regions
7. Gout Therapeutics Market Company Profiles
For more information on this report at: https://bit.ly/2yJVP3l
Related Report:
Global Gout Therapeutics Market Size, Status and Forecast 2019-2025
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com
Source: MarketersMedia
Release ID: 88905880
More News
Worried about losing creativity and other skills to AI? You’re not alone
Many of us fear AI weakens independent thought, creativity and learning, especially among young people who may rely on it to think for them.
This city slicker took a job in Darwin. What happened next surprised her
Long-time city dweller Emma Jane Edwards decided to move on whim 18 months ago.
They transformed the Espy. Now they want to revive a vacant Fitzroy pub
Five mates who launched a pub empire in their 20s have purchased a historic pub in Brunswick Street.
Why your closest friends probably won’t help you find a job
The surprising reality is that your next career move will probably emerge from the very edge of your orbit.
My accent is unremarkable. But it has almost certainly helped me
There’s a type of bias holding us back, economically and socially. Here’s how the way we speak might be shaping how people perceive us.
‘Hard to say there won’t be job cuts’, freshly arrived ABC news chief declares
In his first big day greeting staff, Simon Robinson did not confirm there would be job cuts, but pointedly avoided ruling out redundancies.
Qantas ground staff set to strike over ‘Joyce-era’ bargaining agreements
The 600 workers poised to go on strike are the last remaining Qantas ground workers, after 1800 of their colleagues were illegally sacked during the COVID pandemic.
‘They’re wolves’: Coles keeps milk prices higher despite axing farmer support
The supermarket giant started charging customers more when war broke out in the Middle East to support farmers. Now it and a Woolworths supplier have ended subsidies.
ASX gains as oil prices, bond yields ease; Big four banks advance
The Australian sharemarket has risen for the second day in a row after the Federal Reserve’s first interest rate rise in three years and a drop in oil prices.
Why AI hasn’t taken your job yet
The predicted AI job apocalypse hasn’t landed yet. But the industry is more concerned about the bigger problem of human extinction.
KPMG consultant admits to ‘gaps’ in its whistleblower report
A comprehensive report on KPMG’s whistleblower failings has come up short, as key staff weren’t interviewed and there were no records of crucial meetings.
Dalaroo survey lights up deep WA copper-nickel-PGE targets
Dalaroo Metals has homed in on priority drill targets at its Watheroo copper-nickel-PGE project in WA, after a new IP survey confirmed prior exploration indicators.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.